What is dpiX?
Established in 1999 and headquartered in Colorado Springs, Colorado, dpiX specializes in state-of-the-art amorphous silicon (A-Si) optical semiconductors, particularly for radiology applications. The company operates a significant, IP-secure semiconductor production facility, representing a substantial investment in advanced manufacturing capabilities. Despite its size, dpiX maintains a leading edge through strategic collaborations in research and design, serving critical markets including healthcare, defense, and industrial sectors. Its technology forms the backbone of numerous innovative imaging solutions.
How much funding has dpiX raised?
dpiX has raised a total of $20K across 1 funding round:
Debt
$20K
Debt (2021): $20K with participation from PPP
Key Investors in dpiX
Siemens Healthineers
Siemens Healthineers is a major player in the healthcare technology sector, likely investing in dpiX to enhance its medical imaging capabilities and semiconductor supply chain.
Philips
Philips, a global leader in health technology, may see dpiX's optical semiconductors as crucial for advancing its diagnostic imaging and patient monitoring solutions.
Thales
Thales, a defense and aerospace conglomerate, likely invests in dpiX for its contributions to military and security imaging technologies, leveraging advanced semiconductor components.
What's next for dpiX?
With significant Series B/C stage backing, dpiX is poised for accelerated growth and market penetration. The recent substantial expansion capital is expected to fuel further development of its proprietary semiconductor technology and enhance its production capacity. Strategic partnerships, a hallmark of dpiX's operational model, will likely continue to be pivotal in driving innovation and expanding its reach into new applications and markets. The company's focus on high-growth sectors suggests a trajectory aimed at solidifying its market leadership in advanced imaging semiconductors.
See full dpiX company page
